The second part of the study design was aimed at establishing the Ki-67 index of astrocytic tumor samples and determining whether the index can be used as a discriminating factor when determining the WHO grade of the tumor sample and establishing the relevance of the Ki-67 index to patient survival. This evidence concerns the gene MKI67 and neoplasm.